fluorodeoxyglucose f18 has been researched along with Adenoma, Prolactin-Secreting, Pituitary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balink, H; Collins, J; Gemmel, F; Oomen, P | 1 |
| Daemen, BJ; Doorenbos, H; Elsinga, PH; Paans, AM; Vaalburg, W; Zwertbroek, R | 1 |
2 other study(ies) available for fluorodeoxyglucose f18 and Adenoma, Prolactin-Secreting, Pituitary
| Article | Year |
|---|---|
Occult prolactinoma diagnosed by FDG PET/CT.
Topics: Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Pituitary Neoplasms; Positron-Emission Tomography; Prolactinoma; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2010 |
PET studies with L-[1-11C]tyrosine, L-[methyl-11C]methionine and 18F-fluorodeoxyglucose in prolactinomas in relation to bromocryptine treatment.
Topics: Adult; Bromocriptine; Carbon Radioisotopes; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Methionine; Middle Aged; Pituitary Neoplasms; Prolactinoma; Tomography, Emission-Computed; Tyrosine | 1991 |